中国癌症杂志
中國癌癥雜誌
중국암증잡지
CHINA ONCOLOGY
2001年
2期
131-133,136
,共4页
吴炅%邵志敏%张家新%张亚伟%庄传经%张锡珍%陆劲松%韩企夏%沈镇宙
吳炅%邵誌敏%張傢新%張亞偉%莊傳經%張錫珍%陸勁鬆%韓企夏%瀋鎮宙
오경%소지민%장가신%장아위%장전경%장석진%륙경송%한기하%침진주
乳腺癌%手术%保留乳房
乳腺癌%手術%保留乳房
유선암%수술%보류유방
目的:研究规范病例的选择、手术的范围及术后辅助治疗的方式,使早期乳腺癌的保乳治疗取得良好的局部控制水平、生存率及生活质量。方法:1995年10月—2000年2月,对78例早期乳腺癌病例实施了保乳治疗。手术指征:肿瘤最大直径≤3cm,周围型肿块,年龄≤65岁,病人有保留乳房的意愿,乳房足够大,以保证术后有良好的外形。手术方式为肿块广泛切除加腋淋巴结清扫;肿块位于乳腺外上象限者,原发灶与腋窝行整块切除。术后常规行辅助放疗及化疗。结果:手术标本各个切缘的组织病理切片检查未发现肿瘤累及。13例为导管内癌,9例特殊型浸润性癌,56例为浸润性导管癌;8例患者腋淋巴结发现癌转移,中位淋巴结转移个数为3个(1—8)。中位随访时间22个月。尚无局部及区域复发的病例。有1例远处转移,转移部位是胸膜,手术至转移间期30个月。对40名保乳治疗满一年的病例行乳房外形的随访,两侧乳头水平高度相差>3cm有7例(17.5%),两侧乳房下皱褶水平高度相差>3cm有3例(7.5%),两侧乳头与胸骨中线距离相差>1.5cm有2例(5%)。结论:规范的广泛切除、腋淋巴结清扫及术后辅助放疗是早期乳腺癌保乳治疗的关键措施,可使局部复发率降低;同时保乳治疗后大多数病例能够保持良好的乳房外形。
目的:研究規範病例的選擇、手術的範圍及術後輔助治療的方式,使早期乳腺癌的保乳治療取得良好的跼部控製水平、生存率及生活質量。方法:1995年10月—2000年2月,對78例早期乳腺癌病例實施瞭保乳治療。手術指徵:腫瘤最大直徑≤3cm,週圍型腫塊,年齡≤65歲,病人有保留乳房的意願,乳房足夠大,以保證術後有良好的外形。手術方式為腫塊廣汎切除加腋淋巴結清掃;腫塊位于乳腺外上象限者,原髮竈與腋窩行整塊切除。術後常規行輔助放療及化療。結果:手術標本各箇切緣的組織病理切片檢查未髮現腫瘤纍及。13例為導管內癌,9例特殊型浸潤性癌,56例為浸潤性導管癌;8例患者腋淋巴結髮現癌轉移,中位淋巴結轉移箇數為3箇(1—8)。中位隨訪時間22箇月。尚無跼部及區域複髮的病例。有1例遠處轉移,轉移部位是胸膜,手術至轉移間期30箇月。對40名保乳治療滿一年的病例行乳房外形的隨訪,兩側乳頭水平高度相差>3cm有7例(17.5%),兩側乳房下皺褶水平高度相差>3cm有3例(7.5%),兩側乳頭與胸骨中線距離相差>1.5cm有2例(5%)。結論:規範的廣汎切除、腋淋巴結清掃及術後輔助放療是早期乳腺癌保乳治療的關鍵措施,可使跼部複髮率降低;同時保乳治療後大多數病例能夠保持良好的乳房外形。
목적:연구규범병례적선택、수술적범위급술후보조치료적방식,사조기유선암적보유치료취득량호적국부공제수평、생존솔급생활질량。방법:1995년10월—2000년2월,대78례조기유선암병례실시료보유치료。수술지정:종류최대직경≤3cm,주위형종괴,년령≤65세,병인유보류유방적의원,유방족구대,이보증술후유량호적외형。수술방식위종괴엄범절제가액림파결청소;종괴위우유선외상상한자,원발조여액와행정괴절제。술후상규행보조방료급화료。결과:수술표본각개절연적조직병리절편검사미발현종류루급。13례위도관내암,9례특수형침윤성암,56례위침윤성도관암;8례환자액림파결발현암전이,중위림파결전이개수위3개(1—8)。중위수방시간22개월。상무국부급구역복발적병례。유1례원처전이,전이부위시흉막,수술지전이간기30개월。대40명보유치료만일년적병례행유방외형적수방,량측유두수평고도상차>3cm유7례(17.5%),량측유방하추습수평고도상차>3cm유3례(7.5%),량측유두여흉골중선거리상차>1.5cm유2례(5%)。결론:규범적엄범절제、액림파결청소급술후보조방료시조기유선암보유치료적관건조시,가사국부복발솔강저;동시보유치료후대다수병례능구보지량호적유방외형。
Purpose:To ensure good survival rate and quality of life for early stage breast cancer patients, we standardized the eligibility of breast conservation, the range of resection and post-operative adjuvant management.Methods:During October 1995 to Feburary 2000, 78 early stage breast carcinoma patients received breast-conserving treatment in our hospital. The eligibility of patients is: patients with peripheral breast tumor measuring up to 3 cm in the maximum diameter at clinical examination, and they were under 65 and desired to preserve their breast. Treatment of the primary was wide exision of tumor and axillary lymph node dissection. When the primary carcinoma was located in the upper-outer quadrant, quadrantectomy and axillary dissection were done en bloc. Adjuvant irradiation and chemotherapy was given postoperatively.Results:All the breast specimens were examined and no positive margins were found. 13 cases were ductal carcinoma in situ(DCIS), 8 cases were special type infiltrative carcinoma, and 56 cases were infiltrative ductal carcinoma. 8 patients were axillary lymph node positive, the median of positive nodes was 3(1—8). The median time of follow up was 22 months. There was no local reccurence in our group. Distant metastasis occurred in 1 case, and the site of metastasis was pleura, the time of appearance from surgery was 30 months. 40 patients, who received breast preserving treatment 12 months previously, were evaluated for cosmetic results. We found 7 cases(18%) with >3 cm in height between nipples, 3 cases (8%) with > 3cm in height between inferior profiles of breasts, and 2 cases(5%) with >1.5 cm in length between median line and nipples. Conclusions:For early stage breast carcinoma patients, classic quadrantectomy, axillary dissection and post-operative adjuvant radiotherapy lead to excellent local control and good cosmetic results.